Company intelligence / Profile preview

Vein Clinics of America

Ownership: Private
Development stage: Phase 3

Overview

Merged into USA Vein Clinics in October2022 after40+ years of operation. Specialized in non-surgical treatments for venous diseases using sclerotherapy, endovenous laser therapy (EVLT), and radiofrequency ablation (RFA).

Therapeutic areas: CardiovascularDermatology
Modalities: Minimally invasive vein treatments
Industry: Non-Academic Healthcare

Drug pipeline

2 assets

CardiAMP Cell Therapy System

Phase 3

Indications: Heart failure, Chronic myocardial ischemia

1 more asset in the full pipeline.

Request access →

Partnerships

Insurance providers (Medicare and major insurers)

Beyond the preview

Go deeper on Vein Clinics of America.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vein Clinics of America.

Explore the full profile